Clinical Trial Update: Study On The Performance And Safety Of The REVISYON SDS 100 Device On Visual Acuity In Subjects With Cataract [NA]

View source ↗

Summary

Clinical trial update reporting on performance and safety of the REVISYON SDS 100 device for improving visual acuity in age-related cataract; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Cataract

Drugs mentioned

• REVISYON SDS 100

Snippet

Sponsor: Edinburgh Biosciences Ltd | Conditions: Age-related Cataract | NA | Status: COMPLETED